发明名称 |
METHODS FOR DETERMINING THE EFFICACY OF PD-1 ANTAGONISTS |
摘要 |
PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist. Methods are also disclosed for determining the efficacy of a PD-1 antagonist in a subject administered the PD-1 antagonist. In some embodiments, these methods include measuring proliferation of memory B cells in a sample from a subject administered the PD-1 antagonist. |
申请公布号 |
HUE028582(T2) |
申请公布日期 |
2016.12.28 |
申请号 |
HUE09829832 |
申请日期 |
2009.11.27 |
申请人 |
Emory University;Dana-Farber Cancer Institute, Inc. |
发明人 |
AHMED, Rafi;AMARA, Rama;VELU, Vijayakumar;TITANJI, Kehmia;FREEMAN, Gordon |
分类号 |
A61K39/39;A61K39/00;C07K16/28;G01N33/50 |
主分类号 |
A61K39/39 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|